載入...

4CPS-109 Experience of regorafenib use in metastatic colorectal cancer

BACKGROUND: Regorafenib has been approved for the treatment of patients with previously treated metastatic colorectal cancer (mCRC), and may be considered as a treatment for selected patients. PURPOSE: To evaluate the efficacy and safety of regorafenib treatment in patients with mCRC. MATERIAL AND M...

全面介紹

Na minha lista:
書目詳細資料
發表在:Eur J Hosp Pharm
Main Authors: Mateos, E, Alamo, AM, Vaswani, A Ramchandani, Pin, M Lombardero, López, ME Luján, García, JA Rodriguez, Villalustre, C Otero, Vera, D Fernandez
格式: Artigo
語言:Inglês
出版: BMJ Group 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535196/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.200
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!